Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and lowers the price target from $152 to $133.
Baird analyst Ghansham Panjabi maintains AptarGroup (NYSE:ATR) with a Outperform and lowers the price target from $160 to $145.
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U....
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies,...
